ROSE Diagnostics

ROSE Diagnostics' objective is to improve cancer diagnostics by moving the pathology lab to the cancer biopsy clinic

Health and bio

ROSE Diagnostics has no funding amount on record yet; its latest known round is Seed (Jul 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• EB
  Eric Brouwer Founder

  source: crunchbase.com

Raise history

1. July 17, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related other companies

• WWedding WeekenderOct 1, 2026
• RR2CreteOct 1, 2026
• AAdaptCloseSep 30, 2026
• EElredo VoiceSep 29, 2026
• FFIG LivingSep 29, 2026
• PPakajoSep 29, 2026
• NNovuxSep 29, 2026
• MMurrmurSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rose-diagnostics.